ConductScience.org, home

Paper6138080

Pharmacokinetics and bioavailability of midazolam in man.

Heizmann P and 2 others. Br J Clin Pharmacol, 1983. Cited by 255 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics and bioavailability of midazolam in man. Papers, record 6138080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6138080

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and bioavailability of midazolam in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
255
iCite
Relative citation ratio, by iCite
12.5
iCite
Revised in PubMed
2019-05-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heizmann PP
2Eckert MM
3Ziegler WHW H

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
BenzodiazepinesMajor topic
Administration, Oral
Adult
Biological Availability
Humans
Hydroxylation
Injections, Intravenous
Kinetics
Midazolam

Source PubMed

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,388Determination of water soluble imidazo-1,4-benzodiazepines in blood by electron- capture gas--liquid chromatography and in urine by differential pulse polaragraphy.J Chromatogr1978https://conductscience.org/library/papers/23388PubMed
26,114,686Automated gas chromatography for studies of midazolam pharmacokinetics.Anesthesiology1981https://conductscience.org/library/papers/6114686PubMed
36,116,606The pharmacokinetics of midazolam in man.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6116606PubMed
47,199,324Excretion and metabolism of 14C-midazolam in humans following oral dosing.Arzneimittelforschung1981https://conductscience.org/library/papers/7199324PubMed

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.

PMIDTitleJournalYearIn PapersSource
42,771,268Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/42771268PubMed
42,625,210Introduction to Single-Cell Physiologically-Based Pharmacokinetic (scPBPK) Models.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42625210PubMed
42,033,156Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic Approach.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42033156PubMed
41,961,126A structure-preserving hybrid learning framework for compartmental pharmacokinetic models.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/41961126PubMed
41,959,229Introduction to Single-cell Physiologically-Based Pharmacokinetic (scPBPK) Models.bioRxiv2026https://conductscience.org/library/papers/41959229PubMed
41,667,911Analysis of the Correlation Between Membrane Permeability in RPMI 2650 Cells and Human Nasal Absorption.AAPS PharmSciTech2026https://conductscience.org/library/papers/41667911PubMed
41,489,333Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites.J Med Chem2026https://conductscience.org/library/papers/41489333PubMed
41,255,293
The Ketamine Trial for Acute Suicidality (KETA): Study Protocol of a Double-Blind Randomized Placebo-Controlled Superiority Trial on Intranasal Racemic Ketamine Compared to the Active Placebo Intranasal Midazolam as Treatment for Acute Suicidality.
Int J Methods Psychiatr Res2025https://conductscience.org/library/papers/41255293PubMed
40,829,518A primary human Gut/Liver microphysiological system to estimate human oral bioavailability.Drug Metab Dispos2025https://conductscience.org/library/papers/40829518PubMed
40,700,225Sedation Methods in Paediatric Auditory Electrophysiologic Testing: A Narrative Review.Audiol Res2025https://conductscience.org/library/papers/40700225PubMed
38,403,792Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study.Sci Rep2024https://conductscience.org/library/papers/38403792PubMed
38,370,247Benefits of remimazolam as an anesthetic sedative for older patients: A review.Heliyon2024https://conductscience.org/library/papers/38370247PubMed
38,361,163Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care.Clin Pharmacokinet2024https://conductscience.org/library/papers/38361163PubMed
37,242,680Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients.Pharmaceutics2023https://conductscience.org/library/papers/37242680PubMed
36,642,822Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.Clin Transl Sci2023https://conductscience.org/library/papers/36642822PubMed
36,195,807Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.Clin Pharmacokinet2022https://conductscience.org/library/papers/36195807PubMed
35,994,774A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine.Int J Neuropsychopharmacol2022https://conductscience.org/library/papers/35994774PubMed
35,776,074Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 Patients.Clin Pharmacol Ther2022https://conductscience.org/library/papers/35776074PubMed
35,648,149Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.Eur J Clin Pharmacol2022https://conductscience.org/library/papers/35648149PubMed
35,388,227The pharmacokinetics and pharmacodynamics of midazolam after intravenous administration to donkeys (Equus africanus asinus).Can J Vet Res2022https://conductscience.org/library/papers/35388227PubMed

See all 96 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6138080

GET https://conductscience.org/api/papers/v1/6138080/cited_by?page=2